Journal article

Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors

E Honrado, A Osorio, J Palacios, RL Milne, L Sanchez, O Diez, A Cazorla, K Syrjakoski, D Huntsman, N Heikkila, E Lerma, A Kallioniemi, C Rivas, WD Foulkes, H Nevanlinna, J Benitez

Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2005


PURPOSE: Morphologic and immunohistochemical studies of familial breast cancers have identified specific characteristics associated with BRCA1 mutation-associated tumors when compared with BRCA2 and non-BRCA1/2 tumors, but have not identified differences between BRCA2 and non-BRCA1/2 tumors. Because BRCA1 and BRCA2 genes participate in the DNA repair pathway, we have performed an immunohistochemical study with markers related to this pathway to establish the profile of the three groups. MATERIALS AND METHODS: We have studied two tissue microarrays that include 103 familial and 104 sporadic breast tumors, with a panel of DNA repair markers including ATM, CHEK2, RAD51, RAD50, XRCC3, and prolif..

View full abstract